Evidence map›Paper›PMID 39463656›Full record

ArticleCureus2024

Inflammatory Myofibroblastic Tumor of the Lung: A Case Report.

Marianthi Baltagianni, Vasileios Leivaditis, Nikolaos Baltayiannis, Gabriela Stanc, Efstathia Souka, Pella Batika, Eleftherios Beltsios, Francesk Mulita, Athanasios Papatriantafyllou, Efstratios N Koletsis

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marianthi BaltagianniDepartment of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.
Vasileios LeivaditisDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, DEU.
Nikolaos BaltayiannisDepartment of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.
Gabriela StancDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, GRC.
Efstathia SoukaDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, GRC.
Pella BatikaDepartment of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.
Eleftherios BeltsiosDepartment of Anesthesiology and Critical Care, Hannover Medical School, Hannover, DEU.
Francesk MulitaDepartment of Surgery, General University Hospital of Patras, Patras, GRC.
Athanasios PapatriantafyllouDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, DEU.
Efstratios N KoletsisDepartment of Cardiothoracic Surgery, General University Hospital of Patras, Patras, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor classified as an intermediate malignancy that rarely metastasizes. The most common site for IMTs is the lung, though they can develop in various other anatomical locations. Pulmonary IMTs are more common in children and adolescents and are infrequently diagnosed in adults. This case report describes a 49-year-old woman with a history of breast cancer previously treated with subtotal mastectomy and chemotherapy who developed an IMT in the lung. This case emphasizes the rarity of the disease and the associated clinical challenges when managing such cases.

Indexed as

inflammationinflammatory myofibroblastic tumorlung tumormesenchymal tumorthoracic

Identifiers

PMID39463656
PMCPMC11510679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.